COCONUT OIL: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Coconut oil comes from the nut (fruit) of the coconut palm. It contains medium-chain fatty acids, including capric acid, caprylic acid, and lauric acid.

About 52% to 85% of coconut oil is made up of specific saturated fats, called medium-chain fatty acids. It has a moisturizing effect when applied to the skin.

People commonly use coconut oil for eczema and growth in premature infants. It's also used for psoriasis, obesity, breast cancer, heart disease, MS, and many other conditions, but there is no good scientific evidence to support these uses.

Uses & Effectiveness

Possibly Effective for

Eczema (atopic dermatitis). Applying coconut oil to the skin can reduce eczema symptoms in children more than applying mineral oil.
Growth and development in premature infants. Applying coconut oil to the skin of premature infants might improve body temperature, breathing, skin health, and overall growth.

There is interest in using coconut oil for a number of other purposes, but there isn't enough reliable information to say whether it might be helpful.

Side Effects

When taken by mouth: Coconut oil is commonly consumed in foods. But coconut oil contains a type of fat (saturated fat) that can increase cholesterol levels. Like all saturated fats, it should be consumed in moderation. Coconut oil is possibly safe when used as a medicine short-term. Taking coconut oil in doses of 10 mL two or three times daily for up to 12 weeks seems to be safe.

When applied to the skin: Coconut oil is likely safe when applied to the skin.

Special Precautions and Warnings

Pregnancy and breast-feeding: Coconut oil is commonly consumed in foods. There isn't enough reliable information to know if coconut oil is safe to use as medicine when pregnant or breast-feeding. Stay on the safe side and stick to food amounts.

Children: Coconut oil is possibly safe when applied to the skin for about one month. There isn't enough reliable information to know if coconut oil is safe for children when taken by mouth as a medicine.

High cholesterol: Coconut oil contains a type of fat that can increase cholesterol levels. Regularly eating meals containing coconut oil can increase levels of low-density lipoprotein (LDL or "bad") cholesterol. This might be a problem for people who already have high cholesterol.

Interactions

We currently have no information for COCONUT OIL overview.

Dosing

Coconut oil has most often been used by adults in doses of 20-60 mL by mouth daily for up to 4 months. Coconut oil is also used as a topical oil or moisturizer and is found in some cosmetics. Speak with a healthcare provider to find out what type of product and dose might be best for a specific condition.

Some coconut oil products are referred to as "virgin" coconut oil, which usually means they haven't been bleached, deodorized, or refined. But there aren't any specific industry standards. "Cold pressed" coconut oil means that it's been pressed without a heat source.

View References

REFERENCES:

Lozano, Fernandez R. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases. Arzneimittelforschung. 1983;33(7A):1073-1080. View abstract.

Lukas, S. E., Kouri, E. M., Rhee, C., Madrid, A., and Renshaw, P. F. Effects of short-term citicoline treatment on acute cocaine intoxication and cardiovascular effects. Psychopharmacology.(Berl.) 2001;157(2):163-167. View abstract.

Madariaga Aguirre L. A double-blind evaluation on a group of senile female patients, treated with CDP-choline. Revista de Psiquiatría y Psicología Médica 1978;13(5):331-342.

Marcantonio, E. R., Flacker, J. M., Wright, R. J., and Resnick, N. M. Reducing delirium after hip fracture: a randomized trial. J Am.Geriatr Soc 2001;49(5):516-522. View abstract.

Marti Masso, J. F. and Urtasun, M. Citicoline in the treatment of Parkinson's disease. Clin.Ther 1991;13(2):239-242. View abstract.

Motta L, Fichera G, Tiralosi G, and et al. CDP-choline in the treatment of chronic cerebrovasculopaties [La citicolina nel tratta mento delle cerebrovasculopatie croniche]. Unpublished Lederle (Cyanamid Italia) report. 1985;

Parisi, V., Coppola, G., Centofanti, M., Oddone, F., Angrisani, A. M., Ziccardi, L., Ricci, B., Quaranta, L., and Manni, G. Evidence of the neuroprotective role of citicoline in glaucoma patients. Prog.Brain.Res 2008;173:541-554. View abstract.

Parisi, V., Coppola, G., Ziccardi, L., Gallinaro, G., and Falsini, B. Cytidine-5'-diphosphocholine (Citicoline): a pilot study in patients with non-arteritic ischaemic optic neuropathy. Eur.J Neurol. 2008;15(5):465-474. View abstract.

Parisi, V., Manni, G., Colacino, G., and Bucci, M. G. Cytidine-5'-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma. Ophthalmology. 1999;106(6):1126-1134. View abstract.

Pecori, Giraldi J., Virno, M., Covelli, G., Grechi, G., and De, Gregorio F. Therapeutic value of citicoline in the treatment of glaucoma (computerized and automated perimetric investigation). Int Ophthalmol. 1989;13(1-2):109-112. View abstract.

Petkov, V. D., Stancheva, S. L., Tocuschieva, L., and Petkov, V. V. Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats). Gen.Pharmacol. 1990;21(1):71-75. View abstract.

Piccoli, F., Battistini, N., Carbonin, P., Curro, Dossi B., Fiori, L., La, Bella, V, Megna, G., Salvioli, G., and Fioravanti, M. CDP-choline in the treatment of chronic cerebrovasculopathies. Arch Gerontol Geriatr 1994;18(3):161-168. View abstract.

Radad K, Gille G, Xiaojing J, Durany N, and Rausch W-D. CDP-choline reduces dopaminergic cell loss induced by MPP-super(+) and glutamate in primary mesencephalic cell culture. International Journal of Neuroscience 2007;117(7):985-998.

Renshaw, P. F., Daniels, S., Lundahl, L. H., Rogers, V., and Lukas, S. E. Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report. Psychopharmacology.(Berl.) 1999;142(2):132-138. View abstract.

Rossi, M. and Zanardi, M. [An open study on the clinical efficacy of citicoline in patients with chronic cerebral vasculopathy]. Clin.Ter. 1993;142(2):141-144. View abstract.

Salvadorini F. Clinical evaluation of CDP-choline (Nicholin): Efficacy as antidepressant treatment. Therapeutic Research 1975;18(3):513-520.

Secades, J. J. and Lorenzo, J. L. Citicoline: pharmacological and clinical review, 2006 update. Methods.Find.Exp.Clin.Pharmacol. 2006;28 Suppl B:1-56. View abstract.

Secades, J. J., Alvarez-Sabin, J., Rubio, F., Lozano, R., Davalos, A., and Castillo, J. Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot study. Cerebrovasc.Dis. 2006;21(5-6):380-385. View abstract.

Senin U and Fioravanti M. Clinical controlled study vs placebo of CDPcholine in a large group of aged patients with cerebrovascular dementia. Wyeth, Italy 2003;

Serra, F., Diaspri, G. P., Gasbarrini, A., Giancane, S., Rimondi, A., Tame, M. R., Sakellaridis, E., Bernardi, M., and Gasbarrini, G. [Effect of CDP-choline on senile mental deterioration. Multicenter experience on 237 cases]. Minerva Med. 1990;81(6):465-470. View abstract.

Siddiqi, N., Stockdale, R., Britton, A. M., and Holmes, J. Interventions for preventing delirium in hospitalised patients. Cochrane Database.Syst.Rev. 2007;(2):CD005563. View abstract.

Sinforiani E, Trucco M, Pacchetti C, and et al. Assessment of CDPcholine effects in patients with chronic cerebrovascular disease [Valutazione degli effetti della citicolina nella malattia cerebro-vascolare cronica]. Minerva Medica 1986;77(51):57.

Sinforiani, E., Trucco, M., Pacchetti, C., and Gualtieri, S. [Evaluation of the effects of citicoline in chronic cerebrovascular diseases]. Minerva Med 1-14-1986;77(1-2):51-57. View abstract.

Stramba-Badiale, M. and Scillieri, E. [Citicoline activity in senile mental decay]. Minerva Med 4-7-1983;74(14-15):819-821. View abstract.

Suryani L, Adnjana T, and Jensen G. Citicholine treatment of memory deficits in elderly people. International Journal of Geriatric Psychiatry 1988;3(3):235-236.

Tanaka, Y., Minematsu, K., Hirano, T., Hayashida, K., and Yamaguchi, T. [Effects of CDP-choline on dynamic changes in LCBF and cognitive function in demented subjects--an H2 15O-PET study]. Rinsho.Shinkeigaku. 1994;34(9):877-881. View abstract.

Trovarelli, G., de Medio, G. E., Dorman, R. V., Piccinin, G. L., Horrocks, L. A., and Porcellati, G. Effect of cytidine diphosphate choline (CDP-choline) on ischemia-induced alterations of brain lipid in the gerbil. Neurochem.Res 1981;6(8):821-833. View abstract.

Virno, M., Pecori-Giraldi, J., Liguori, A., and De, Gregorio F. The protective effect of citicoline on the progression of the perimetric defects in glaucomatous patients (perimetric study with a 10-year follow-up). Acta Ophthalmol.Scand.Suppl 2000;(232):56-57. View abstract.

Warach, S., Pettigrew, L. C., Dashe, J. F., Pullicino, P., Lefkowitz, D. M., Sabounjian, L., Harnett, K., Schwiderski, U., and Gammans, R. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann.Neurol. 2000;48(5):713-722. View abstract.

Xiong, Y., Liu, X., Wang, Y., and Du, Y. Cloning of cytidine triphosphate: phosphocholine cytidylyltransferase mRNA upregulated by a neuropeptide arginine-vasopressin((4-8)) in rat hippocampus. Neurosci.Lett. 4-7-2000;283(2):129-132. View abstract.

Yashima, K., Takamatsu, M., and Okuda, K. Intestinal absorption of cytidine diphosphate choline and its changes in the digestive tract. J Nutr Sci Vitaminol.(Tokyo) 1975;21(1):49-60. View abstract.

Adibhatla RM, Hatcher JF. Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia. J Neurosci Res 2003;73:308-15. View abstract.

Adibhatla RM, Hatcher JF. Citicoline mechanisms and clinical efficacy in cerebral ischemia. J Neurosci Res 2002;70:133-9. View abstract.

Aidelbaum R, Labelle A, Baddeley A, Knott V. Assessing the acute effects of CDP-choline on sensory gating in schizophrenia: a pilot study. J Psychopharmacol. 2018;32(5):541-51. View abstract.

Babb SM, Appelmans KE, Renshaw PF, et al. Differently effect of CDP-choline on brain cytosolic choline levels in younger and older subjects as measured by magnetic resonance spectroscopy. Psychopharmacology (Berl) 1996;127:88-94. View abstract.

Barrachina M, Dominguez I, Ambrosio S, et al. Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells. J Neurol Sci 2003;215:105-10. View abstract.

Brown ES, Todd JP, Hu LT, et al. A randomized, double-blind, placebo-controlled trial of citicoline for cocaine dependence in bipolar I disorder. Am J Psychiatry 2015;172(10):1014-21. View abstract.

Castagna A, Manzo C, Fabbo A, Lacava R, Ruberto C, Ruotolo G. The CITIMERIVA Study: CITIcoline plus MEmantina plus RIVAstigmine in Older Patients Affected with Alzheimer's Disease. Clin Drug Investig. 2021 Feb;41(2):177-182. View abstract.

Cinar E, Yuce B, Aslan F, Erbakan G. Neuroprotective effect of citicoline eye drops on corneal sensitivity after LASIK. J Refract Surg. 2019 Dec 1;35(12):764-770. View abstract.

Clark BC, Georgekutty J, Berul CI. Myocardial ischemia secondary to synthetic cannabinoid (K2) use in pediatric patients. J Pediatr 2015;167(3):757-61.e1. View abstract.

Cohen RA, Browndyke JN, Moser DJ, et al. Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: Neuroimaging and neuropsychological outcomes. Cerebrovasc Dis 2003;16:199-204. View abstract.

Conant R, Schauss AG. Therapeutic applications of citicoline for stroke and cognitive function in the elderly: A review of the literature. Altern Med Rev 2004;9:17-31. View abstract.

Cotroneo AM, Castagna A, Putignano S, et al. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clin Interv Aging 2013;8:131-7. View abstract.

Dávalos A, Alvarez-Sabín J, Castillo J, et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 2012;380(9839):349-57. View abstract.

Davalos A, Castillo J, Alvarez-Sabin J, et al. Oral citicoline in acute ischemic stroke: An individual patient date pooling analysis of clinical trials. Stroke 2002;33:2850-7. View abstract.

Dempsey RJ, Raghavendra Rao VL. Cytidinediphosphocholine treatment to decrease traumatic brain injury-induced hippocampal neuronal death, cortical contusion volume, and neurological dysfunction in rats. J Neurosurg 2003;98:867-73. View abstract.

El Sayed I, Zaki A, Fayed AM, Shehata GM, Abdelmonem S. A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury. Neurosurg Rev 2018;41(2):427-38. View abstract.

Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev 2005;(2):CD000269. View abstract.

Fogagnolo P, Melardi E, Tranchina L, Rossetti L. Topical citicoline and vitamin B12 versus placebo in the treatment of diabetes-related corneal nerve damage: a randomized double-blind controlled trial. BMC Ophthalmol. 2020 Aug 1;20(1):315.View abstract.

Oliveira-de-Lira L, Santos EMC, de Souza RF, et al. Supplementation-dependent effects of vegetable oils with varying fatty acid compositions on anthropometric and biochemical parameters in obese women. Nutrients. 2018;10(7). pii: E932. View abstract.

Platero JL, Cuerda-Ballester M, Ibáñez V, et al. The impact of coconut oil and epigallocatechin gallate on the levels of IL-6, anxiety and disability in multiple sclerosis patients. Nutrients. 2020;12(2). pii: E305. View abstract.

Platero JL, Cuerda-Ballester M, Sancho-Cantus D, et al. The impact of epigallocatechin gallate and coconut oil treatment on cortisol activity and depression in multiple sclerosis patients. Life (Basel) 2021;11(4):353. View abstract.

Quimby AE, Hogan D, Khalil D, Hearn M, Nault C, Johnson-Obaseki S. Coconut oil as a novel approach to managing radiation-induced xerostomia: a primary feasibility study. Int J Otolaryngol 2020;2020:8537643. View abstract.

Reiser R, Probstfield JL, Silvers A, et al. Plasma lipid and lipoprotein response of humans to beef fat, coconut oil and safflower oil. Am J Clin Nutr 1985;42:190-7. View abstract.

Ripari F, Filippone F, Zumbo G, Covello F, Zara F, Vozza I. The role of coconut oil in treating patients affected by plaque-induced gingivitis: a pilot study. Eur J Dent 2020;14(4):558-65. View abstract.

Romer H, Guerra M, Pina JM, et al. Realimentation of dehydrated children with acute diarrhea: comparison of cow's milk to a chicken-based formula. J Pediatr Gastroenterol Nutr 1991;13:46-51. View abstract.

Ruppin DC, Middleton WR. Clinical use of medium chain triglycerides. Drugs 1980;20:216-24.

Sacks FM, Lichtenstein AH, Wu JHY, et al.; American Heart Association. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation 2017;136(3):e1-e23. View abstract.

Salam RA, Darmstadt GL, Bhutta ZA. Effect of emollient therapy on clinical outcomes in preterm neonates in Pakistan: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F210-5. View abstract.

Sankaranarayanan K, Mondkar JA, Chauhan MM, et al. Oil massage in neonates: an open randomized controlled study of coconut versus mineral oil. Indian Pediatr 2005;42:877-84. View abstract.

Saraogi P, Kaushik V, Chogale R, Chavan S, Gode V, Mhaskar S. Virgin coconut oil as prophylactic therapy against alcohol damage on skin in COVID times. J Cosmet Dermatol 2021;20(8):2396-2408. View abstract.

Sezgin Y, Memis Ozgul B, Alptekin NO. Efficacy of oil pulling therapy with coconut oil on four-day supragingival plaque growth: A randomized crossover clinical trial. Complement Ther Med. 2019;47:102193. View abstract.

Siripaiboonpong N, Matangkasombut O, Pengcharoen H, Boonchaiyapluk B, Rujiraprasert P, Srithanyarat SS. Microbiological effects of virgin coconut oil pulling in comparison with palm oil pulling as an adjunctive oral hygiene care for patients with gingival inflammation: a randomized controlled clinical trial. J Indian Soc Periodontol. 2022 Jan-Feb;26(1):58-63. View abstract.

Strunk T, Gummer JPA, Abraham R, et al. Topical Coconut Oil Contributes to Systemic Monolaurin Levels in Very Preterm Infants. Neonatology. 2019;116(3):299-301. View abstract.

Strunk T, Pupala S, Hibbert J, Doherty D, Patole S. Topical coconut oil in very preterm infants: an open-label randomized controlled trial. Neonatology. 2017 Dec 1;113(2):146-151. View abstract.

Swarnamali H, Ranasinghe P, Hills AP, Jayawardena R. Coconut oil consumption and bodyweight reduction: a systematic review and meta-analysis. Minerva Endocrinol (Torino) 2021. View abstract.

Tella R, Gaig P, Lombardero M, et al. A case of coconut allergy. Allergy 2003;58:825-6.

Teng M, Zhao YJ, Khoo AL, Yeo TC, Yong QW, Lim BP. Impact of coconut oil consumption on cardiovascular health: a systematic review and meta-analysis. Nutr Rev. 2020;78(3):249-259. View abstract.

Teuber SS, Peterson WR. Systemic allergic reaction to coconut (Cocos nucifera) in 2 subjects with hypersensitivity to tree nut and demonstration of cross-reactivity to legumin-like seed storage proteins: new coconut and walnut food allergens. J Allergy Clin Immunol 1999;103:1180-5. View abstract.

Valente FX, Cândido FG, Lopes LL, et al. Effects of coconut oil consumption on energy metabolism, cardiometabolic risk markers, and appetitive responses in women with excess body fat. Eur J Nutr. 2018;57(4):1627-1637. View abstract.

Vijayakumar M, Vasudevan DM, Sundaram KR, et al. A randomized study of coconut oil versus sunflower oil on cardiovascular risk factors in patients with stable coronary heart disease. Indian Heart J. 2016 Jul-Aug;68(4):498-506. View abstract.

Voon PT, Ng TK, Lee VK, Nesaretnam K. Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Am J Clin Nutr 2011;94:1451-7. View abstract.

Weerakoon WNMTDN, Anjali NVP, Jayathilaka N, Seneviratne KN. Soybean oil and coconut oil enhance the absorption of chlorogenic acid in humans. J Food Biochem 2021;e13823. View abstract.

Zakaria ZA, Rofiee MS, Somchit MN,et al. Hepatoprotective activity of dried- and fermented-processed virgin coconut oil. Evid Based Complement Alternat Med 2011;2011:142739. View abstract.

The Latest Treatments for Moderate-to-Severe Psoriasis

What You Should Know About Psoriasis

Unmasking Psoriasis in Diverse Skin Tones

Psoriasis: Choosing Treatment

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.

COCONUT OIL - Uses, Side Effects, and More